Taskin, O. Et Al. 2006. Endometrial receptivity following use of 2.5 and 5 mg (day 3-7) letrozole in CC-resistant patients with PCOS.. 62nd Annual Meeting of the American-Society-for-Reproductive-Medicine , (Louisiana, United States Of America).

Taskin, O., Akar, M. E., AKKOYUNLU, G., Ozekinci, M., Demir, R., & Sadik, S., (2006). Endometrial receptivity following use of 2.5 and 5 mg (day 3-7) letrozole in CC-resistant patients with PCOS. . 62nd Annual Meeting of the American-Society-for-Reproductive-Medicine, Louisiana, United States Of America

Taskin, ÖMÜR Et Al. "Endometrial receptivity following use of 2.5 and 5 mg (day 3-7) letrozole in CC-resistant patients with PCOS.," 62nd Annual Meeting of the American-Society-for-Reproductive-Medicine, Louisiana, United States Of America, 2006

Taskin, ÖMÜR Et Al. "Endometrial receptivity following use of 2.5 and 5 mg (day 3-7) letrozole in CC-resistant patients with PCOS.." 62nd Annual Meeting of the American-Society-for-Reproductive-Medicine , Louisiana, United States Of America, 2006

Taskin, O. Et Al. (2006) . "Endometrial receptivity following use of 2.5 and 5 mg (day 3-7) letrozole in CC-resistant patients with PCOS.." 62nd Annual Meeting of the American-Society-for-Reproductive-Medicine , Louisiana, United States Of America.

@conferencepaper{conferencepaper, author={ÖMÜR TAŞKIN Et Al. }, title={Endometrial receptivity following use of 2.5 and 5 mg (day 3-7) letrozole in CC-resistant patients with PCOS.}, congress name={62nd Annual Meeting of the American-Society-for-Reproductive-Medicine}, city={Louisiana}, country={United States Of America}, year={2006}}